Dentsply Sirona Inc

Dentsply Sirona reported second quarter revenue of $898 million, beating analyst estimates of $892.6 million, while adjusted EPS of $0.52 far exceeded the $0.35 consensus, yet shares declined following the announcement. The company reconfirmed full-year revenue guidance of $3.55 billion at the midpoint and reiterated adjusted EPS guidance of $1.45 at the midpoint. CEO Daniel Scavilla described the current phase as a turnaround, noting uneven improvement across segments and geographies, with lower sales volumes in the Americas and EMEA and ongoing challenges in capital equipment demand and distributor inventory reduction. During the earnings call, analysts questioned the timing of EPS improvement, the impact of tariff refunds on guidance, and the pace of U.S. commercial team productivity gains, with Scavilla indicating most benefits from recent hires and dealer additions will be realized in the fourth quarter and next year, and tariff refunds were not embedded in guidance.

Dentsply Sirona reported second quarter 2026 revenue of $898 million, a 4.1% reported decline or 6.3% on a constant currency basis, while adjusted EPS was flat year over year at $0.52 including a $0.17 per share positive impact from tariff refunds. The company recorded a $44 million tariff refund in the quarter, which it used partially to fund opportunistic share repurchases of 1.3 million shares for approximately $12 million at an average price below $10 per share. Operating cash flow rose to $99 million from $48 million in the prior year quarter, driven by the tariff refund and improved management of accounts payable and inventory. Full-year revenue guidance of $3.5 billion to $3.6 billion and adjusted EPS guidance of $1.40 to $1.50 were maintained, excluding the benefit from tariff refunds and the impact of incremental tariffs. Management expects third quarter revenue to decline sequentially due to seasonality and earnings to be below second quarter levels excluding the tariff refund, with improvement weighted toward the fourth quarter.

The four dental equipment and technology stocks tracked by StockStory reported strong first-quarter results, with aggregate revenues beating analysts' consensus estimates by 3% while next-quarter revenue guidance was in line. Dentsply Sirona posted flat revenue of $880 million, exceeding expectations by 4.8%, but its stock fell 10% since reporting. Envista delivered the fastest revenue growth among its peers at 14.4% to $705.5 million, yet shares declined 6.7%. Henry Schein, the weakest performer against estimates, saw revenue rise 6.3% to $3.37 billion and its stock gained 11.2%. Align Technology reported a 6.2% revenue increase to $1.04 billion, beating estimates, but its stock dropped 6.3%. On average, share prices across the group are down 2.9% since the latest earnings results.